1 / 4

Global Rheumatoid Arthritis Drugs Market Size

Global Rheumatoid Arthritis Drugs Market Insights<br>Rheumatoid Arthritis Drugs Market size was valued at USD 59.031 billion in 2021 and is poised to grow from USD 60.02 billion in 2022 to USD 70 billion by 2030, growing at a CAGR of 1.72% in the forecast period (2023-2030).<br>Rheumatoid arthritis affects people of all ages, although the geriatric population is highly vulnerable to the diseases. The symptoms majorly include joint pain, stiffness, tenderness, and swelling. As per the statistics published by WHO, rheumatoid arthritis affected around 400 out of 100,000 people between 1980 and 2019.

Ritanshu
Download Presentation

Global Rheumatoid Arthritis Drugs Market Size

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Rheumatoid Arthritis Drugs Market Size, Share, Growth Analysis, By Drug Class by Route of Administration by Sales Channel by Molecule - Industry Forecast 2023- 2030

  2. Global Rheumatoid Arthritis Drugs Market Insights Rheumatoid Arthritis Drugs Market size was valued at USD 59.031 billion in 2021 and is poised to grow from USD 60.02 billion in 2022 to USD 70 billion by 2030, growing at a CAGR of 1.72% in the forecast period (2023-2030). Rheumatoid arthritis affects people of all ages, although the geriatric population is highly vulnerable to the diseases. The symptoms majorly include joint pain, stiffness, tenderness, and swelling. As per the statistics published by WHO, rheumatoid arthritis affected around 400 out of 100,000 people between 1980 and 2019. Despite high prevalence, it does not have 100% cure. The major factors driving growth in the Global market are an increase in the prevalence of rheumatoid arthritis, an increase in demand for rheumatoid arthritis drugs, the expiration of patents and the entry of biosimilar drugs, an increase in the geriatric population, an increase in the adoption of conventional DMARDs, and government initiatives to spread awareness of rheumatoid arthritis symptoms. sophisticated biologics, an increase in healthcare expenditure, an increase in purchasing power, and global access to quality pharmaceuticals for poor and middle-class families are some of the factors driving Global Rheumatoid Arthritis Drugs Market expansion. Furthermore, advancements in Global Rheumatoid Arthritis Drugs Market Segmental Analysis Global Rheumatoid Arthritis Drugs market is segmented by Drug Class into Disease-modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, and Uric Acid Drugs. By molecule, the market is

  3. segmented into Pharmaceuticals and Biopharmaceuticals. By Route of Administration, the market is segmented into Oral and Parenteral. By Sales Channel the market is segmented into Prescription Drugs and OTC drugs. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA. Rheumatoid Arthritis Drugs Market Analysis by Drug Class Currently, disease-modifying anti-rheumatic medicines (DMARDs) are the leading revenue contributors and are expected to expand significantly in the Global Rheumatoid Arthritis Drugs Market during the forecast period. The increase in DMARD awareness, surge in rheumatoid arthritis prevalence, rise in obese & overweight population globally, and increase in usage of DMARDs as a first-line treatment for rheumatoid arthritis are the important reasons driving global market growth. Get the best overview of Global Rheumatoid Arthritis Drugs Market https://www.skyquestt.com/report/rheumatoid-arthritis-drugs-market Top Player’s in Global Rheumatoid Arthritis Drugs Market •Pfizer Inc. •Johnson & Johnson Services, Inc. •AbbVie Inc. •Amgen Inc. •Bristol Myers Squibb Co. •Celgene Corporation •Eli Lilly and Company •F. Hoffmann-La Roche AG •GlaxoSmithKline plc •Merck & Co., Inc.

  4. •Novartis International AG About Us: Sky Quest Technology is leading growth consulting firm providing market intelligence, commercialization, and technology services. It has 450+ happy clients globally. Address: 1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 617-230-0741 Email:sales@skyquestt.com Sky Quest

More Related